Literature DB >> 21289688

Are your patients protected from rubeola?

W Feldman.   

Abstract

Patients have a 95% chance of being protected from rubeola if they received the proper vaccine, stored and handled in the correct manner, at the appropriate age. An increase in measles in teenagers is more likely due to technical problems (the vaccine, storage, handling, and age of administration) than to waning immunity. Provincial governments should follow the U.S. lead and mount programs to eradicate measles, just as we have done with smallpox. For patients whose immune status is unknown, serology should be done and only the susceptibles vaccinated.

Entities:  

Year:  1981        PMID: 21289688      PMCID: PMC2305903     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  7 in total

1.  STUDIES ON IMMUNITY TO MEASLES.

Authors:  S KRUGMAN; J P GILES; H FRIEDMAN; S STONE
Journal:  J Pediatr       Date:  1965-03       Impact factor: 4.406

2.  Follow-up surveillance for antibody in human subjects following live attenuated measles, mumps, and rubella virus vaccines.

Authors:  R E Weibel; E B Buynak; A A McLean; M R Hilleman
Journal:  Proc Soc Exp Biol Med       Date:  1979-11

3.  Measles immune-status surveys in Manitoba.

Authors:  L Sekla; W Stackiw; M Drewniak
Journal:  Can J Public Health       Date:  1979 Nov-Dec

4.  The 'new' epidemiology of measles and rubella.

Authors:  J D Cherry
Journal:  Hosp Pract       Date:  1980-07

5.  Evidence for reinstatement of infants 12 to 14 months of age into routine measles immunization programs.

Authors:  J Wilkins; P F Wehrle
Journal:  Am J Dis Child       Date:  1978-02

6.  Epidemic measles in young adults. Clinical, epidemiologic, and serologic studies.

Authors:  P J Krause; J D Cherry; J Deseda-Tous; J G Champion; M Strassburg; C Sullivan; M J Spencer; Y J Bryson; R C Welliver; K M Boyer
Journal:  Ann Intern Med       Date:  1979-06       Impact factor: 25.391

7.  Additional evidence against measles vaccine administration to infants less than 12 months of age: altered immune response following active/passive immunization.

Authors:  J Wilkins; P F Wehrle
Journal:  J Pediatr       Date:  1979-06       Impact factor: 4.406

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.